Mariana G Figueiro1, Barbara Plitnick1, Charles Roohan1, Levent Sahin1, Michael Kalsher2, Mark S Rea1. 1. Lighting Research Center, Rensselaer Polytechnic Institute, Troy, New York, United States. 2. Cognitive Science Department, School of Humanities, Arts and Social Sciences, Rensselaer Polytechnic Institute, Troy, New York, United States.
Abstract
STUDY OBJECTIVES: We investigated the effectiveness of a lighting intervention tailored to maximally affect the circadian system as a nonpharmacological therapy for treating problems with sleep, mood, and behavior in persons with Alzheimer disease and related dementias (ADRD). METHODS: This 14-week randomized, placebo-controlled, crossover design clinical trial administered an all-day active or control lighting intervention to 46 patients with ADRD in 8 long-term care facilities for two 4-week periods (separated by a 4-week washout). The study employed wrist-worn actigraphy measures and standardized measures of sleep quality, mood, and behavior. RESULTS: The active intervention significantly improved Pittsburgh Sleep Quality Index scores compared to the active baseline and control intervention (mean ± SEM: 6.67 ± 0.48 after active intervention, 10.30 ± 0.40 at active baseline, 8.41 ± 0.47 after control intervention). The active intervention also resulted in significantly greater active versus control differences in intradaily variability. As for secondary outcomes, the active intervention resulted in significant improvements in Cornell Scale for Depression in Dementia scores (mean ± SEM: 10.30 ± 1.02 at baseline, 7.05 ± 0.67 after active intervention) and significantly greater active versus control differences in Cohen-Mansfield Agitation Inventory scores (mean ± SEM: -5.51 ± 1.03 for the active intervention, -1.50 ± 1.24 for the control intervention). CONCLUSIONS: A lighting intervention tailored to maximally entrain the circadian system can improve sleep, mood, and behavior in patients with dementia living in controlled environments. CLINICAL TRIAL REGISTRATION: Registry: ClinicalTrials.gov, title: Methodology Issues in a Tailored Light Treatment for Persons With Dementia, URL: https://clinicaltrials.gov/ct2/show/NCT01816152, identifier: NCT01816152.
RCT Entities:
STUDY OBJECTIVES: We investigated the effectiveness of a lighting intervention tailored to maximally affect the circadian system as a nonpharmacological therapy for treating problems with sleep, mood, and behavior in persons with Alzheimer disease and related dementias (ADRD). METHODS: This 14-week randomized, placebo-controlled, crossover design clinical trial administered an all-day active or control lighting intervention to 46 patients with ADRD in 8 long-term care facilities for two 4-week periods (separated by a 4-week washout). The study employed wrist-worn actigraphy measures and standardized measures of sleep quality, mood, and behavior. RESULTS: The active intervention significantly improved Pittsburgh Sleep Quality Index scores compared to the active baseline and control intervention (mean ± SEM: 6.67 ± 0.48 after active intervention, 10.30 ± 0.40 at active baseline, 8.41 ± 0.47 after control intervention). The active intervention also resulted in significantly greater active versus control differences in intradaily variability. As for secondary outcomes, the active intervention resulted in significant improvements in Cornell Scale for Depression in Dementia scores (mean ± SEM: 10.30 ± 1.02 at baseline, 7.05 ± 0.67 after active intervention) and significantly greater active versus control differences in Cohen-Mansfield Agitation Inventory scores (mean ± SEM: -5.51 ± 1.03 for the active intervention, -1.50 ± 1.24 for the control intervention). CONCLUSIONS: A lighting intervention tailored to maximally entrain the circadian system can improve sleep, mood, and behavior in patients with dementia living in controlled environments. CLINICAL TRIAL REGISTRATION: Registry: ClinicalTrials.gov, title: Methodology Issues in a Tailored Light Treatment for Persons With Dementia, URL: https://clinicaltrials.gov/ct2/show/NCT01816152, identifier: NCT01816152.
Authors: Debra Saliba; Joan Buchanan; Maria Orlando Edelen; Joel Streim; Joseph Ouslander; Dan Berlowitz; Joshua Chodosh Journal: J Am Med Dir Assoc Date: 2012-07-15 Impact factor: 4.669
Authors: Sonia Ancoli-Israel; Jennifer L Martin; Philip Gehrman; Tamar Shochat; Jody Corey-Bloom; Matthew Marler; Sarah Nolan; Leah Levi Journal: Am J Geriatr Psychiatry Date: 2003 Mar-Apr Impact factor: 4.105
Authors: Arthur S Walters; Cheryl LeBrocq; Anjana Dhar; Wayne Hening; Ray Rosen; Richard P Allen; Claudia Trenkwalder Journal: Sleep Med Date: 2003-03 Impact factor: 3.492
Authors: A B Douglass; R Bornstein; G Nino-Murcia; S Keenan; L Miles; V P Zarcone; C Guilleminault; W C Dement Journal: Sleep Date: 1994-03 Impact factor: 5.849
Authors: Rixt F Riemersma-van der Lek; Dick F Swaab; Jos Twisk; Elly M Hol; Witte J G Hoogendijk; Eus J W Van Someren Journal: JAMA Date: 2008-06-11 Impact factor: 56.272
Authors: Susan E Hickman; Ann Louise Barrick; Christianna S Williams; Sheryl Zimmerman; Bettye Rose Connell; John S Preisser; C Madeline Mitchell; Philip D Sloane Journal: J Am Geriatr Soc Date: 2007-10-16 Impact factor: 5.562
Authors: Stephanie L Harrison; Suzanne M Dyer; Kate E Laver; Rachel K Milte; Richard Fleming; Maria Crotty Journal: Cochrane Database Syst Rev Date: 2022-03-07
Authors: Ingrid Goudriaan; Leonieke C van Boekel; Marjolein E A Verbiest; Joost van Hoof; Katrien G Luijkx Journal: Clin Interv Aging Date: 2021-05-24 Impact factor: 4.458